Literature DB >> 20818131

Abnormal myocardial capillary density in apical hypertrophic cardiomyopathy can be assessed by myocardial contrast echocardiography.

Jeonggeun Moon1, In Jeong Cho, Chi Young Shim, Jong-Won Ha, Yangsoo Jang, Namsik Chung, Se-Joong Rim.   

Abstract

BACKGROUND: Myocardial ischemia and dysfunction can occur in hypertrophic cardiomyopathy (HCM) because of the high muscle-to-blood ratio, even without significant coronary artery disease. Microbubbles reside only in the intravascular space and myocardial video-intensity during systole results mostly from microbubbles within capillaries. The hypothesis explored in the present study was that an abnormal capillary density in apical HCM (ApHCM) can be demonstrated using myocardial contrast echocardiography (MCE). METHODS AND
RESULTS: The 56 patients were investigated (31 males, age 58 ± 9 years; 33 ApHCM, 9 hypertensive left ventricular hypertrophy [LVH], 14 controls). MCE was performed with low-mechanical-index power modulation imaging. Tissue Doppler imaging to assess myocardial contractile function was obtained at the mitral annulus (S'), and (99 m)Tc-MIBI SPECT was also performed. All ApHCM patients exhibited perfusion defects at the hypertrophied segments in the systolic phase during MCE, whereas SPECT showed normal or rather increased perfusion at those sites. The cyclic variation of video-intensity was exaggerated in ApHCM when compared with the LVH or control group (% of [systolic video-intensity]/[diastolic video-intensity]: 33.0 ± 12.3%, 88.3 ± 19.2% and 79.4 ± 13.9%, respectively [P<0.05]). Concurrently, MCE cyclic variation and perfusion defect size were related to decreased S' (P<0.05 for all).
CONCLUSIONS: A perfusion defect at the hypertrophied segment, representing abnormal myocardial capillary density, was observed in ApHCM patients during MCE. The extent of MCE cyclic variation and the perfusion defect size both correlate with decreased myocardial contractile property in ApHCM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20818131     DOI: 10.1253/circj.cj-10-0241

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  Apical hypertrophic cardiomyopathy.

Authors:  Raymond F Stainback
Journal:  Tex Heart Inst J       Date:  2012

Review 2.  Assessment and Treatment for Coronary Microvascular Dysfunction by Contrast Enhanced Ultrasound.

Authors:  Junzhen Zhan; Longhe Zhong; Juefei Wu
Journal:  Front Cardiovasc Med       Date:  2022-06-20

Review 3.  Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy.

Authors:  Richard J Marszalek; R John Solaro; Beata M Wolska
Journal:  Pflugers Arch       Date:  2018-10-29       Impact factor: 3.657

4.  Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy.

Authors:  Paola Roldan; Sriram Ravi; James Hodovan; J Todd Belcik; Stephen B Heitner; Ahmad Masri; Jonathan R Lindner
Journal:  Cardiovasc Ultrasound       Date:  2022-09-19       Impact factor: 2.263

5.  Differences of left ventricular systolic deformation in hypertensive patients with and without apical hypertrophic cardiomyopathy.

Authors:  Yu-Cheng Kao; Ming-Feng Lee; Chun-Tai Mao; Wei-Siang Chen; Ning-I Yang; Wen-Jin Cherng; Ming-Jui Hung
Journal:  Cardiovasc Ultrasound       Date:  2013-11-14       Impact factor: 2.062

Review 6.  Cardiotoxicity with vascular endothelial growth factor inhibitor therapy.

Authors:  Rhian M Touyz; Joerg Herrmann
Journal:  NPJ Precis Oncol       Date:  2018-05-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.